Americans pay far higher prices for prescription drugs than do people in other wealthy countries. The reason that other countries spend so much less on drugs is that their governments negotiate prices with the pharmaceutical industry. The United States government could adopt the same approach with the Medicare drug program and use its market leverage to negotiate the same, or even lower, prices as are paid by other wealthy nations.
According to a new issue brief from Center for Economic Policy and Research, such a system would save Washington state between $500 million and $1.2 billion over 10 years. The potential savings to all states would be enormous, cumulatively between $31 billion and $73 billion over 10 years.
Every state individually could expect significant savings. California leads the way, with potential savings between $3.3 and $7.8 billion. The next six top-saving states are Florida, New York, Texas, Pennsylvania, Ohio and Illinois, all with projected savings of at least $1 billion per year. Even those states with the least potential savings, such as Wyoming, North Dakota and Vermont, would still save tens of millions of dollars over a decade.
More To Read
April 17, 2024
2023-24 Impact and Gratitude Report
Reflecting on a year of progress and transition at EOI
April 12, 2024
Welcoming our New Executive Director, Rian Watt!
EOI is excited to begin its next chapter under new leadership
April 4, 2024
Is There a Valid Argument Against Cost-Free College in Washington?
Cost-free college is a meaningful investment that would change lives. What's stopping Washington from making it happen?